Crossref
Drug development blossoms for rare, fatal bone disease
Science · 2024
DOI: 10.1126/science.adq7356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2024. Verfasst von Mitch Leslie. Hauptthemen laut MEDLINE: Bone Diseases, Drug Development, Rare Diseases, Myositis Ossificans. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Five drugs are now approved or in trials for genetic condition that triggers misplaced bone growth
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Bone DiseasesDrug DevelopmentRare DiseasesMyositis OssificansHumansAntibodies, MonoclonalDrug Approval
Substanzen
Antibodies, Monoclonal
Zitieren
APA
Leslie, M. (2024). Drug development blossoms for rare, fatal bone disease. Science. https://doi.org/10.1126/science.adq7356
Vancouver
Leslie M. Drug development blossoms for rare, fatal bone disease. Science. 2024. doi:10.1126/science.adq7356
BibTeX
@article{Leslie2024,
author = {Leslie, Mitch},
title = {Drug development blossoms for rare, fatal bone disease},
journal = {Science},
year = {2024},
doi = {10.1126/science.adq7356}
}
EUVIMED